Featured2 years ago
Immutep Limited (NASDAQ: IMMP) Immuno-oncology Breakthrough with Phase 2 Trial Combining Merck & Co’s Keytruda
Immutep Limited (NASDAQ: IMMP) flew by an impressive 122% at the time of writing after positive news on their Phase II trial, which is a collaboration...